Skip to main content
Top
Published in: Journal of Urban Health 1/2007

01-01-2007

Design and Feasibility of a Randomized Behavioral Intervention to Reduce Distributive Injection Risk and Improve Health-Care Access Among hepatitisC virus Positive Injection Drug Users: The Study to Reduce Intravenous Exposures (STRIVE)

Authors: Farzana Kapadia, Mary H. Latka, Holly Hagan, Elizabeth T. Golub, Jennifer V. Campbell, Micaela H. Coady, Richard S. Garfein, David L. Thomas, Sebastian Bonner, Thelma Thiel, Steffanie A. Strathdee

Published in: Journal of Urban Health | Issue 1/2007

Login to get access

Abstract

Hepatitis C virus (HCV) is hyperendemic among injection drug users (IDUs). However, few scientifically proven interventions to prevent secondary transmission of HCV from infected IDUs to others exist. This report describes the design, feasibility, and baseline characteristics of participants enrolled in the Study to Reduce Intravenous Exposure (STRIVE). STRIVE was a multisite, randomized-control trial to test a behavioral intervention developed to reduce distribution of used injection equipment (needles, cookers, cottons, and rinse water) and increase health-care utilization among antibody HCV (anti-HCV) positive IDUs. STRIVE enrolled anti-HCV positive IDU in Baltimore, New York City, and Seattle; participants completed behavioral assessments and venipuncture for HIV, HCV-RNA, and liver function tests (LFTs) and were randomized to attend either a six-session, small-group, peer-mentoring intervention workshop or a time-matched, attention-control condition. Follow-up visits were conducted at 3 and 6 months. At baseline, of the 630 HCV-positive IDUs enrolled (mean age of 26 years, 60% white, 76% male), 55% reported distributive needle sharing, whereas 74, 69, and 69% reported sharing cookers, cottons, and rinse water, respectively. Health-care access was low, with 41% reporting an emergency room as their main source of medical care. Among those enrolled, 66% (418/630) were randomized: 53% (222/418) and 47% (196/418) to the intervention and control conditions, respectively. Follow-up rates were 70 and 73% for the 3- and 6-month visits, respectively. As distributive sharing of used injection equipment was common while reports of receiving HCV care were low, these findings indicate an urgent need for HCV-related interventions with IDUs and demonstrate the acceptability and feasibility to do so.
Literature
1.
go back to reference NIH consensus statement on management of hepatitis C: 2002. NIH Consens State Sci Statements. 2002;19:1–46. NIH consensus statement on management of hepatitis C: 2002. NIH Consens State Sci Statements. 2002;19:1–46.
3.
go back to reference Yen T, Keeffe EB, Ahmed A. The epidemiology of hepatitis C virus infection. J Clin Gastroenterol. 2003;36:47–53.PubMedCrossRef Yen T, Keeffe EB, Ahmed A. The epidemiology of hepatitis C virus infection. J Clin Gastroenterol. 2003;36:47–53.PubMedCrossRef
4.
5.
go back to reference Thorpe LE, Ouellet LJ, Hershow R, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002;155:645–653.PubMedCrossRef Thorpe LE, Ouellet LJ, Hershow R, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002;155:645–653.PubMedCrossRef
6.
go back to reference Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Human Retrovirol. 1998;18(Suppl 1):S11–S19. Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Human Retrovirol. 1998;18(Suppl 1):S11–S19.
7.
go back to reference Thorpe L, Ouellet L, Hershow R, Bailey S, Williams I, Monerosso E. The multiperson use of non-syringe injection equipment and risk of hepatitis c infection in a cohort of young adult injection drug users in Chicago, 1997–1999. Ann Epidemiol. 2000;10:472–473.PubMedCrossRef Thorpe L, Ouellet L, Hershow R, Bailey S, Williams I, Monerosso E. The multiperson use of non-syringe injection equipment and risk of hepatitis c infection in a cohort of young adult injection drug users in Chicago, 1997–1999. Ann Epidemiol. 2000;10:472–473.PubMedCrossRef
8.
go back to reference Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health. 2001;91:42–46.PubMed Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health. 2001;91:42–46.PubMed
9.
go back to reference Gerberding JL. Management of occupational exposures to blood-borne viruses. N Engl J Med. 1995;332:444–451.PubMedCrossRef Gerberding JL. Management of occupational exposures to blood-borne viruses. N Engl J Med. 1995;332:444–451.PubMedCrossRef
10.
go back to reference Hagan H, Des Jarlais DC. HIV and HCV infection among injecting drug users. Mt Sinai J Med. 2000;67:423–428.PubMed Hagan H, Des Jarlais DC. HIV and HCV infection among injecting drug users. Mt Sinai J Med. 2000;67:423–428.PubMed
11.
go back to reference Stoove MA, Gifford SM, Dore GJ. The impact of injecting drug use status on hepatitis C-related referral and treatment. Drug Alcohol Depend. 2005;77:81–86.PubMedCrossRef Stoove MA, Gifford SM, Dore GJ. The impact of injecting drug use status on hepatitis C-related referral and treatment. Drug Alcohol Depend. 2005;77:81–86.PubMedCrossRef
12.
13.
go back to reference Strauss SM, Astone JM, Jarlais DD, Hagan H. A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States. Drug Alcohol Depend. 2004;73:227–236.PubMedCrossRef Strauss SM, Astone JM, Jarlais DD, Hagan H. A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States. Drug Alcohol Depend. 2004;73:227–236.PubMedCrossRef
14.
go back to reference Ompad DC, Fuller CM, Vlahov D, Thomas D, Strathdee SA. Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clin Infect Dis. 2002;35:783–788.PubMedCrossRef Ompad DC, Fuller CM, Vlahov D, Thomas D, Strathdee SA. Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clin Infect Dis. 2002;35:783–788.PubMedCrossRef
15.
go back to reference Hagan H, McGough JP, Thiede H, Weiss NS, Hopkins S, Alexander ER. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol. 1999;149:203–213.PubMed Hagan H, McGough JP, Thiede H, Weiss NS, Hopkins S, Alexander ER. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol. 1999;149:203–213.PubMed
16.
go back to reference Crofts N, Nigro L, Oman K, Stevenson E, Sherman J. Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction. 1997;92:999–1005.PubMedCrossRef Crofts N, Nigro L, Oman K, Stevenson E, Sherman J. Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction. 1997;92:999–1005.PubMedCrossRef
17.
go back to reference Strauss SM, Astone JM, Hagan H, Des J. The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units. J Urban Health. 2004;81:38–47.PubMed Strauss SM, Astone JM, Hagan H, Des J. The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units. J Urban Health. 2004;81:38–47.PubMed
18.
go back to reference Garfein RS, Latka M, Hagan H, et al. CIDUS-III/Drug Users Intervention Trial (DUIT): A Randomized, Controlled Trial of a Peer-Education Behavioral Intervention to Prevent HIV and Hepatitis C Virus Infection Among 15–30 Year Old Injection Drug Users. Paper Presented at: National HIV Prevention Conference; June 12, 2005; Atlanta, GA. Garfein RS, Latka M, Hagan H, et al. CIDUS-III/Drug Users Intervention Trial (DUIT): A Randomized, Controlled Trial of a Peer-Education Behavioral Intervention to Prevent HIV and Hepatitis C Virus Infection Among 15–30 Year Old Injection Drug Users. Paper Presented at: National HIV Prevention Conference; June 12, 2005; Atlanta, GA.
19.
go back to reference Alter MJ, Kuhnert WL, Finelli L. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Morb Mortal Wkly Rep. 2003;52:1–13. Alter MJ, Kuhnert WL, Finelli L. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Morb Mortal Wkly Rep. 2003;52:1–13.
20.
go back to reference Fishbein M, Ajzen F. Belief, Attitude and Behavior: An Introduction to Theory and Research. Reading, MA: Addison-Wesley; 1975. Fishbein M, Ajzen F. Belief, Attitude and Behavior: An Introduction to Theory and Research. Reading, MA: Addison-Wesley; 1975.
21.
go back to reference Montano DE, Kasprzyk D, Taplin SH. The Theory of Reasoned Action and the Theory of Planned Behavior. In: Glanz K, Lewis FM, Rimer BK, eds. Health Behavior and Health Education. San Francisco, CA: Jossey-Bass Publishers; 1997. Montano DE, Kasprzyk D, Taplin SH. The Theory of Reasoned Action and the Theory of Planned Behavior. In: Glanz K, Lewis FM, Rimer BK, eds. Health Behavior and Health Education. San Francisco, CA: Jossey-Bass Publishers; 1997.
22.
go back to reference Bandura A. Self-efficacy mechanism in human agency. Am Psychol. 1986;40:359–373. Bandura A. Self-efficacy mechanism in human agency. Am Psychol. 1986;40:359–373.
23.
go back to reference Bandura A. A Social-Cognitive Approach to the Exercise of Control over AIDS Infection. In: Albee GW, Schneider SF, eds. Primary Prevention of AIDS: Psychological Approaches. Newbury Park, CA: Sage Publications; 1991. Bandura A. A Social-Cognitive Approach to the Exercise of Control over AIDS Infection. In: Albee GW, Schneider SF, eds. Primary Prevention of AIDS: Psychological Approaches. Newbury Park, CA: Sage Publications; 1991.
24.
go back to reference Rothman KJ, Greenland S. Modern Epidemiology, 2nd edition. Philadelphia, PA: Lippincott-Raven; 1998. Rothman KJ, Greenland S. Modern Epidemiology, 2nd edition. Philadelphia, PA: Lippincott-Raven; 1998.
25.
go back to reference Hagan H, Campbell JV, Thiede H, et al. Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep. 2006;121:710–719. Hagan H, Campbell JV, Thiede H, et al. Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep. 2006;121:710–719.
26.
go back to reference Rosenblum A, Nuttbrock L, McQuistion HL, Magura S, Joseph H. Hepatitis C and substance use in a sample of homeless people in New York City. J Addict Dis. 2001;20:15–25.PubMedCrossRef Rosenblum A, Nuttbrock L, McQuistion HL, Magura S, Joseph H. Hepatitis C and substance use in a sample of homeless people in New York City. J Addict Dis. 2001;20:15–25.PubMedCrossRef
27.
go back to reference Klinkenberg WD, Caslyn RJ, Morse GA, et al. Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. Compr Psychiatry. 2003;44:293–302.PubMedCrossRef Klinkenberg WD, Caslyn RJ, Morse GA, et al. Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. Compr Psychiatry. 2003;44:293–302.PubMedCrossRef
28.
go back to reference Stein JA, Nyamathi A. Correlates of hepatitis C virus infection in homeless men: a latent variable approach. Drug Alcohol Depend. 2004;75:89–95.PubMedCrossRef Stein JA, Nyamathi A. Correlates of hepatitis C virus infection in homeless men: a latent variable approach. Drug Alcohol Depend. 2004;75:89–95.PubMedCrossRef
29.
go back to reference Macalino GE, Vlahov D, Sanford-Colby S, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004;94:1218–1223.PubMedCrossRef Macalino GE, Vlahov D, Sanford-Colby S, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004;94:1218–1223.PubMedCrossRef
30.
31.
go back to reference Samuel MC, Doherty PM, Bulterys M, Jenison SA. Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiol Infect. 2001;127:475–484.PubMedCrossRef Samuel MC, Doherty PM, Bulterys M, Jenison SA. Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiol Infect. 2001;127:475–484.PubMedCrossRef
32.
go back to reference Gebo KA, Diener-West M, Moore RD. Hospitalization rates differ by hepatitis C status in an urban HIV cohort. J Acquir Immune Defic Syndr. 2003;34:165–173.PubMedCrossRef Gebo KA, Diener-West M, Moore RD. Hospitalization rates differ by hepatitis C status in an urban HIV cohort. J Acquir Immune Defic Syndr. 2003;34:165–173.PubMedCrossRef
33.
go back to reference Wiegand J, Buggisch P, Boecher W, et al. Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study. Hepatology. 2006;43:250–256.PubMedCrossRef Wiegand J, Buggisch P, Boecher W, et al. Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study. Hepatology. 2006;43:250–256.PubMedCrossRef
34.
go back to reference Jaeckel E, Cornberg M, Wedemeyer H, et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med. 2001;345:1452–1457.PubMedCrossRef Jaeckel E, Cornberg M, Wedemeyer H, et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med. 2001;345:1452–1457.PubMedCrossRef
35.
go back to reference Hagan H, Latka MH, Campbell JV, et al. Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities. Clin Infect Dis. 2006;42:669–672.PubMedCrossRef Hagan H, Latka MH, Campbell JV, et al. Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities. Clin Infect Dis. 2006;42:669–672.PubMedCrossRef
36.
go back to reference Turner CF, Ku L, Rogers SM, Lindberg LD, Pleck JH, Sonenstein FL. Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. Science. 1998;280:867–873.PubMedCrossRef Turner CF, Ku L, Rogers SM, Lindberg LD, Pleck JH, Sonenstein FL. Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. Science. 1998;280:867–873.PubMedCrossRef
37.
go back to reference Des Jarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999;353:1657–1661.PubMedCrossRef Des Jarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999;353:1657–1661.PubMedCrossRef
38.
go back to reference Metzger DS, Koblin B, Turner C, et al. Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol. 2000;152:99–106.PubMedCrossRef Metzger DS, Koblin B, Turner C, et al. Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol. 2000;152:99–106.PubMedCrossRef
Metadata
Title
Design and Feasibility of a Randomized Behavioral Intervention to Reduce Distributive Injection Risk and Improve Health-Care Access Among hepatitisC virus Positive Injection Drug Users: The Study to Reduce Intravenous Exposures (STRIVE)
Authors
Farzana Kapadia
Mary H. Latka
Holly Hagan
Elizabeth T. Golub
Jennifer V. Campbell
Micaela H. Coady
Richard S. Garfein
David L. Thomas
Sebastian Bonner
Thelma Thiel
Steffanie A. Strathdee
Publication date
01-01-2007
Publisher
Springer US
Published in
Journal of Urban Health / Issue 1/2007
Print ISSN: 1099-3460
Electronic ISSN: 1468-2869
DOI
https://doi.org/10.1007/s11524-006-9133-7

Other articles of this Issue 1/2007

Journal of Urban Health 1/2007 Go to the issue